COVID-19: The Pseudo-Environment and the Need for a Paradigm Change

doi:10.18683/germs.2021.1283

Editorial

. 2021 Dec 29;11(4):468-477.

doi: 10.18683/germs.2021.1283. eCollection 2021 Dec.

COVID-19: The Pseudo-Environment and the Need for a Paradigm Change

Richard A Stein¹, Oana Ometa², Thomas R Broker³

Affiliations

¹ MD, PhD, NYU Tandon School of Engineering, Department of Chemical and Biomolecular Engineering, 6 MetroTech Center, Brooklyn, NY 11201, USA.
² PhD, Department of Journalism and Digital Media, Faculty of Political, Administrative and Communication Sciences, Babes-Bolyai University, Cluj-Napoca, Romania.
³ PhD, Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, Alabama 35294-0024, USA.

PMID: 35096665
PMCID: PMC8789355
DOI: 10.18683/germs.2021.1283

Editorial

COVID-19: The Pseudo-Environment and the Need for a Paradigm Change

Richard A Stein et al. Germs. 2021.

. 2021 Dec 29;11(4):468-477.

doi: 10.18683/germs.2021.1283. eCollection 2021 Dec.

Authors

Richard A Stein¹, Oana Ometa², Thomas R Broker³

Affiliations

¹ MD, PhD, NYU Tandon School of Engineering, Department of Chemical and Biomolecular Engineering, 6 MetroTech Center, Brooklyn, NY 11201, USA.
² PhD, Department of Journalism and Digital Media, Faculty of Political, Administrative and Communication Sciences, Babes-Bolyai University, Cluj-Napoca, Romania.
³ PhD, Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, Alabama 35294-0024, USA.

PMID: 35096665
PMCID: PMC8789355
DOI: 10.18683/germs.2021.1283

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None to declare.

Cited by

Knowledge, Attitudes, and Practices of Dental Students from Romania Regarding Self-Perceived Risk and Prevention of Infectious Diseases.
Dincă FI, Dimitriu BA, Săndulescu O, Sîrbu VD, Săndulescu M. Dincă FI, et al. Dent J (Basel). 2024 Apr 10;12(4):97. doi: 10.3390/dj12040097. Dent J (Basel). 2024. PMID: 38668009 Free PMC article.
Tolerance for three commonly administered COVID-19 vaccines by healthcare professionals.
Melanson SEF, Zhao Z, Kumanovics A, Love T, Meng QH, Wu AHB, Apple F, Ondracek CR, Schulz KM, Wiencek JR, Koch D, Christenson R, Zhang YV. Melanson SEF, et al. Front Public Health. 2022 Sep 27;10:975781. doi: 10.3389/fpubh.2022.975781. eCollection 2022. Front Public Health. 2022. PMID: 36238255 Free PMC article.
Evaluation of the Turkish Population's Perspective on COVID-19 Vaccine Hesitancy and Routine Childhood Vaccine Applications: National Survey Study.
Akbulut S, Boz G, Ozer A, Sahin TT, Colak C. Akbulut S, et al. Vaccines (Basel). 2023 Mar 31;11(4):779. doi: 10.3390/vaccines11040779. Vaccines (Basel). 2023. PMID: 37112690 Free PMC article.
Adverse events following immunization (AEFI): COVID-19 vaccine dose and characteristics in Central Java, Indonesia.
Wahyudi F, Nugraheni A, Margawati A, Pramono D, Adespin DA, Nugroho TW, Pramana C. Wahyudi F, et al. Germs. 2023 Mar 31;13(1):40-49. doi: 10.18683/germs.2023.1365. eCollection 2023 Mar. Germs. 2023. PMID: 38023961 Free PMC article.
Pediatric Emergencies and Hospital Admissions in the First Six Months of the COVID-19 Pandemic in a Tertiary Children's Hospital in Romania.
Miron VD, Gunșahin D, Filimon C, Bar G, Craiu M. Miron VD, et al. Children (Basel). 2022 Apr 5;9(4):513. doi: 10.3390/children9040513. Children (Basel). 2022. PMID: 35455557 Free PMC article.

See all "Cited by" articles

References

1. Liu C, Zhou Q, Li Y, et al. Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Cent Sci. 2020;6:315–31. doi: 10.1021/acscentsci.0c00272. - DOI - PMC - PubMed
1. Kaur SP, Gupta V. COVID-19 vaccine: a comprehensive status report. Virus Res. 2020;288:198114. doi: 10.1016/j.virusres.2020.198114. - DOI - PMC - PubMed
1. Tanzi E, Genovese C, Tettamanzi M, Fappani C, Raviglione MC, Amendola A. COVID-19 vaccines: evidence, challenges and the future. J Prev Med Hyg. 2021;62:E18–E29. - PMC - PubMed
1. Lythgoe MP, Middleton P. Comparison of COVID-19 vaccine approvals at the US Food and Drug Administration, European Medicines Agency, and Health Canada. JAMA Netw Open. 2021;4:e2114531. doi: 10.1001/jamanetworkopen.2021.14531. - DOI - PMC - PubMed
1. Food and Drug Administration. 2021. FDA approves first COVID-19 vaccine. [Accessed on: 13 October 2021]. Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-first-c....

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central

[1] Liu C, Zhou Q, Li Y, et al. Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Cent Sci. 2020;6:315–31. doi: 10.1021/acscentsci.0c00272. - DOI - PMC - PubMed

[2] Liu C, Zhou Q, Li Y, et al. Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Cent Sci. 2020;6:315–31. doi: 10.1021/acscentsci.0c00272. - DOI - PMC - PubMed

[3] Kaur SP, Gupta V. COVID-19 vaccine: a comprehensive status report. Virus Res. 2020;288:198114. doi: 10.1016/j.virusres.2020.198114. - DOI - PMC - PubMed

[4] Kaur SP, Gupta V. COVID-19 vaccine: a comprehensive status report. Virus Res. 2020;288:198114. doi: 10.1016/j.virusres.2020.198114. - DOI - PMC - PubMed

[5] Tanzi E, Genovese C, Tettamanzi M, Fappani C, Raviglione MC, Amendola A. COVID-19 vaccines: evidence, challenges and the future. J Prev Med Hyg. 2021;62:E18–E29. - PMC - PubMed

[6] Tanzi E, Genovese C, Tettamanzi M, Fappani C, Raviglione MC, Amendola A. COVID-19 vaccines: evidence, challenges and the future. J Prev Med Hyg. 2021;62:E18–E29. - PMC - PubMed

[7] Lythgoe MP, Middleton P. Comparison of COVID-19 vaccine approvals at the US Food and Drug Administration, European Medicines Agency, and Health Canada. JAMA Netw Open. 2021;4:e2114531. doi: 10.1001/jamanetworkopen.2021.14531. - DOI - PMC - PubMed

[8] Lythgoe MP, Middleton P. Comparison of COVID-19 vaccine approvals at the US Food and Drug Administration, European Medicines Agency, and Health Canada. JAMA Netw Open. 2021;4:e2114531. doi: 10.1001/jamanetworkopen.2021.14531. - DOI - PMC - PubMed

[9] Food and Drug Administration. 2021. FDA approves first COVID-19 vaccine. [Accessed on: 13 October 2021]. Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-first-c....

[10] Food and Drug Administration. 2021. FDA approves first COVID-19 vaccine. [Accessed on: 13 October 2021]. Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-first-c....

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

COVID-19: The Pseudo-Environment and the Need for a Paradigm Change

Affiliations

COVID-19: The Pseudo-Environment and the Need for a Paradigm Change

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources